SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc is surging after a major court victory where a jury awarded significant damages against a competitor for bot fraud, igniting intense community speculation about a potential short squeeze. Investors are aggressively debating the company's valuation and the likelihood of successful collection, while widespread frustration persists over frequent trading halts that have fueled accusations of market manipulation.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh significant long-term growth catalysts, including high-profile partnerships and foundry expansion, against the volatility of upcoming quarterly earnings. The community remains deeply divided, with some actively shorting the stock in anticipation of a post-earnings pullback, while others advocate for a long-term 'buy-and-hold' strategy based on the company's critical role in national infrastructure and AI chip development.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is attracting heavy attention following the official reclassification of state-licensed medical marijuana to Schedule III, a major catalyst that investors believe will alleviate significant tax burdens and improve operational viability. While the news has triggered extreme volatility and intense debate between optimistic bulls betting on a long-term sector transformation and skeptical bears wary of historic dilution and sell-the-news patterns, the community is actively tracking the stock's massive volume spikes as traders position for potential further federal policy shifts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares have plummeted to multi-year lows following the announcement of a new CEO from Nike, a move that has sparked intense debate among investors wary of the hiring choice. While the community is deeply divided between those viewing the stock as a deeply undervalued fundamental play and those concerned about eroding brand relevance, active discussions remain centered on the company's lack of a clear turnaround strategy and broader retail sector weakness.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened volatility and community debate as investors react to a significant equity stake disclosure from Uber, alongside ongoing concerns regarding persistent cash burn and potential dilution. While some market participants see a long-term opportunity in the firm's strategic robotaxi partnerships and Saudi PIF backing, others remain skeptical, pointing to the stock's downward trend and the looming possibility of further capital restructuring.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility and heightened scrutiny as investors debate whether current price action signals a bubble or a temporary consolidation amid rapid AI-driven growth. The community remains sharply divided, with many actively trading leveraged inverse ETFs to hedge against potential downside, while others interpret the recent price swings as controlled accumulation in a sector that continues to serve as a critical proxy for overall market health.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending following an earnings release where despite beating expectations, the stock faced a sharp sell-off due to margin pressure from recent acquisitions and geopolitical headwinds impacting deal flow. The community is actively debating whether this decline represents a fundamental breakdown of the SaaS business model in an AI-driven environment or a temporary valuation reset that creates a buying opportunity for long-term investors.

8i Acquisition 2 Corp. is a blank check company. Its purpose is to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 21, 2021 and is headquartered in Singapore.

Euda Health Holdings Limited

Euda Health Holdings is experiencing significant volatility and momentum as traders closely monitor its low-float status and history of rapid intraday spikes. The community is actively debating the stock's potential for further gains while expressing frustration over frequent trading halts and the speculative nature of its price action.

ASGN Incorporated engages in the provision of information technology services and solutions. It operates through the Commercial and Federal Government segments. The Commercial segment involves the provision of consulting, creative digital marketing, and permanent placement services. The Federal Government segment provides mission-critical solutions. The company was founded on December 30, 1985 and is headquartered in Glen Allen, VA.

ASGN Inc

ASGN Inc. is trending as investors and social media participants debate the company's valuation and long-term outlook amidst broader concerns about demand in the IT staffing sector. The conversation is heavily polarized, featuring discussions on institutional short interest and potential manipulation, while others see value in the company's buyback authorization and market position.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is seeing significant market enthusiasm following strong quarterly results and optimistic guidance, which investors are linking to surging demand for analog chips in AI-driven data center infrastructure. The stock's sharp upward momentum has sparked active community discussion regarding its potential as a long-term beneficiary of hyperscaler growth and a key player in the industrial semiconductor recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8%  - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8% - What's Next...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Large Volume Increase  - Still a Buy?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Strong Trading Volume - Time to Buy...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - What's Next?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - Time to Sell...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Here's What Happened...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 1.3%  - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 1.3% - Should You Sell...

BridgeBio Oncology (BBOT) Spotlights Next-Gen RAS Pipeline, $425M Cash Runway Into 2028

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) used a presentation at Leerink Partners' Global Healthcare Conference to outline its strategy around next-generation RAS therapeutics, highlighting three...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Issues Quarterly Earnings Results

BridgeBio Oncology Therapeutics (NASDAQ:BBOT - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) EPS for the quarter, topping analysts' consensus...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Shares Gap Up After Better-Than-Expected Earnings

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Shares Gap Up Following Better-Than-Expected Earnings...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Price Target Raised to $29.00 at HC Wainwright

HC Wainwright lifted their price target on shares of BridgeBio Oncology Therapeutics from $27.00 to $29.00 and gave the stock a "buy" rating in a report on Friday...

BridgeBio Oncology Touts Best in RAS Pipeline, Highlights BBO-8520 Response and Combo Tolerability

Executives from BridgeBio Oncology Therapeutics (NASDAQ:BBOT) outlined the company's strategy to build what they call the Best in RAS pipeline during an Oppenheimer-hosted discussion, emphasizing...

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.

Current Price	$8.97
Prev Close	$8.87
Open	$8.78
Dividend Yield	0.00%
50-Day Moving Average	$9.59
Beta	2.42
Avg. Volume	158,570.81
PE Ratio	-5.93

52-Week High	$14.87
52-Week Low	$8.08
Market Capitalization	$709.89M
EPS (Annual)	-$4.30
Price to Book	1.73
Revenue Per Employee	$0.00

BBOT
BridgeBio Oncology Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBOT News

BBOTBridgeBio Oncology Therapeutics Inc.